Financhill
Back

Smith & Nephew PLC Quote, Financials, Valuation and Earnings

Smith & Nephew PLC Price Quote

$25.31
+0.01 (+0.64%)
(Updated: November 27, 2024 at 4:41 AM ET)

Smith & Nephew PLC Key Stats

Sell
39
Smith & Nephew PLC (SNN) is a Sell

Day range:
$25.10 - $25.32
52-week range:
$23.65 - $31.72
Dividend yield:
2.96%
P/E ratio:
42.03
P/S ratio:
1.96
P/B ratio:
2.12%

Volume:
522K
Avg. volume:
941.1K
1-year change:
-1.98%
Market cap:
$11B
Revenue:
$5.5B
EPS:
$0.7

How Much Does Smith & Nephew PLC Make?

Is Smith & Nephew PLC Growing As A Company?

  • What Is Smith & Nephew PLC's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.06%
  • What Is Smith & Nephew PLC's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.01%

Smith & Nephew PLC Stock Price Performance

  • Did Smith & Nephew PLC Stock Go Up Last Month?
    Smith & Nephew PLC share price went down by -10.82% last month
  • Did SNN's Share Price Rise Over The Last Year?
    SNN share price fell by -1.98% over the past 1 year

What Is Smith & Nephew PLC 52-Week High & Low?

Smith & Nephew PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Smith & Nephew PLC?

Is Smith & Nephew PLC Cash Flow Positive?

Data Unavailable

Smith & Nephew PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    SNN return on invested capital is 3.68%
  • What Is Smith & Nephew PLC Return On Assets?
    ROA measures how assets are converting to revenues and is 3.01%
  • What Is SNN Return On Equity?
    ROE is a measure of profitability and is 5.85%

Smith & Nephew PLC Earnings Date & Stock Price

Smith & Nephew PLC Competitors

  • Who Are Smith & Nephew PLC's Competitors?
    Below is a list of companies who compete with Smith & Nephew PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Bicycle Therapeutics PLC (BCYC)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • Haleon PLC (HLN)
    • Verona Pharma PLC (VRNA)

Smith & Nephew PLC Dividend Yield

Smith & Nephew PLC Analyst Estimates

YoY Growth Past Surprise
EPS: -1.01% 0%
Revenue: 6.3% -0.37%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 32.55
Upside from Last Price: 28.67%

Major Shareholders

  • How many SNN shares are owned by institutional investors?
    87.4M SNN shares are owned by institutional investors
  • How many SNN shares are owned by insiders?
    2.7M SNN shares are owned by insiders